{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:33:54Z","timestamp":1787070834659,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study explored the impact of short-term coronavirus disease 2019 (COVID-19) restrictions on the efficacy of atropine 0.01% eyedrops on myopia control in a multiethnic cohort of Australian children. In the Western Australia Atropine for the Treatment of Myopia study, 104 and 49 children were randomized to receive atropine 0.01% eyedrops and a placebo, respectively. We compared the 1-year myopia progression and axial elongation following the 2-month lockdown in 2020 to the same months in 2019 and 2021, i.e., the 1-year myopia progression up to May 2019\u2013October 2019 (non-COVID-19) versus the 1-year progression up to May 2020\u2013October 2020 (COVID-19 period), and the 1-year progression up to May 2021\u2013October 2021 (non-COVID-19) versus the 1-year progression up to the same months in 2020. After excluding participants who withdrew, completed their treatment phase prior May 2020, or those whose study visits did not fall between May 2020 and October 2020, 65 participants (mean age at baseline = 11.8 \u00b1 2.5 years) were included in the final analysis (49 in the treatment group; 16 in the placebo group). After correcting for age, sex, and ethnicity, there was no significant main effect of the short-term lockdown on the rate of spherical equivalent or axial length change. However, there was a lockdown \u00d7 treatment interaction effect on the rate of axial elongation (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.007). This was such that in the treatment group, the 1-year axial elongation was faster during lockdown by 0.056 mm compared to the nonlockdown periods (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.009), while the rate of axial elongation in those on the placebo eye drops was similar during lockdown and nonlockdown. Our findings suggest that there is a decreased efficacy of low-concentration atropine even with relatively lenient restrictions lasting for a few months.\n                  <\/jats:p>","DOI":"10.4103\/tjo.tjo-d-24-00025","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T06:00:56Z","timestamp":1718949656000},"page":"262-265","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Impact of coronavirus disease 2019 restrictions on the efficacy of atropine 0.01% eyedrops for myopia control \u2013 Findings from the Western Australia Atropine for the Treatment of Myopia study"],"prefix":"10.4103","volume":"14","author":[{"given":"Samantha Sze-Yee","family":"Lee","sequence":"first","affiliation":[{"name":"Centre for Ophthalmology and Visual Science (Incorporating the Lions Eye Institute), University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Lingham","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology and Visual Science (Incorporating the Lions Eye Institute), University of Western Australia, Perth, Western Australia, Australia"},{"name":"Centre for Eye Research Ireland, Environmental, Sustainability and Health Institute, Technological University Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Mackey","sequence":"additional","affiliation":[{"name":"Centre for Ophthalmology and Visual Science (Incorporating the Lions Eye Institute), University of Western Australia, Perth, Western Australia, Australia"},{"name":"Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Victoria"},{"name":"School of Medicine, Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaophthalmol.2020.6231","article-title":"2020 as the year of quarantine myopia","volume":"139","author":"Klaver","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaophthalmol.2020.6239","article-title":"Progression of myopia in school-aged children after COVID-19 home confinement","volume":"139","author":"Wang","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.3390\/ijerph18105347","article-title":"Impact of COVID-19 home confinement in children's refractive errors","volume":"18","author":"Alvarez-Peregrina","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/s41433-021-01655-2","article-title":"The effect of home education on myopia progression in children during the COVID-19 pandemic","volume":"36","author":"Aslan","year":"2022","journal-title":"Eye (Lond)"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.ophtha.2021.03.029","article-title":"Comparison of myopic progression before, during, and after COVID-19 lockdown","volume":"128","author":"Chang","year":"2021","journal-title":"Ophthalmology"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"101475","DOI":"10.1016\/j.clae.2021.101475","article-title":"Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns","volume":"45","author":"Erdinest","year":"2022","journal-title":"Cont Lens Anterior Eye"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"e0257480","DOI":"10.1371\/journal.pone.0257480","article-title":"Influence of coronavirus disease 2019 on myopic progression in children treated with low-concentration atropine","volume":"16","author":"Yum","year":"2021","journal-title":"PLoS One"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/ceo.14148","article-title":"Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trial","volume":"50","author":"Lee","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/ceo.13736","article-title":"Western Australia atropine for the treatment of myopia (WA-ATOM) study: Rationale, methodology and participant baseline characteristics","volume":"48","author":"Lee","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"key":"R11-20240830","year":"2020","journal-title":"Department of Health Western Australia. Phase 3 of COVID-19 roadmap to commence from saturday. In: Health Do. Perth: Department of Health Western Australia"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1136\/bjophthalmol-2021-319307","article-title":"Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: A population-based prospective study","volume":"106","author":"Zhang","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaophthalmol.2021.3563","article-title":"Rates of myopia development in young Chinese schoolchildren during the outbreak of COVID-19","volume":"139","author":"Hu","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.62.10.37","article-title":"COVID-19 home quarantine accelerated the progression of myopia in children aged 7 to 12 years in China","volume":"62","author":"Ma","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:23Z","timestamp":1787067443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00025","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"2024-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}